MicroRNA-133b Inhibits Cell Proliferation and Invasion in Osteosarcoma by Targeting Sirt1

被引:24
|
作者
Shi Ying [1 ]
Huang Jianjun [2 ]
Yi Xue [1 ]
Yu Shuwei [1 ]
Zhang Liyuan [1 ]
Wang Jie [1 ]
Cheng Lixian [1 ]
机构
[1] Xiamen Med Coll, Dept Pathol, 1999 Guankou Rd, Xiamen 361023, Fujian, Peoples R China
[2] Xiamen HaiCang Hosp, Dept Orthoped, Xiamen, Fujian, Peoples R China
关键词
miR-133b; Sirt1; Osteosarcoma; Proliferation; Invasion; CANCER; PATHWAY;
D O I
10.3727/096504016X14826089198805
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MicroRNAs are a class of small noncoding RNAs that function as critical gene regulators through targeting mRNAs for translational repression or degradation. In this study, we showed that the miR-133b expression level was decreased while the Sirt1 mRNA expression level was increased in osteosarcoma tissue and cell lines. A low expression of miR-133b was significantly associated with tumor size, distant metastasis, and advanced clinical stage. In addition, osteosarcoma patients with a low miR-133b expression showed a worse prognosis when compared to those with a high level of miR-133b expression. Thus, we identified Sirt1 as a novel direct target of miR-133b. Overexpression of miR-133b suppressed Sirt1 expression and attenuated cell proliferation and invasion. Forced expression of Sirt1 could partly rescue the inhibitory effect of miR-133b in osteosarcoma cells. Our finding also suggested that the inhibitory effects of the miR-133b/ Sirt1 axis on osteosarcoma progression were involved in the Wnt/beta-catenin pathway. Taken together, these findings will shed light on the role and mechanism of miR-133b in regulating osteosarcoma cell growth via the miR-133b/ Sirt1 axis, and miR-133b may serve as a potential therapeutic target in osteosarcoma in the future.
引用
收藏
页码:1421 / 1430
页数:10
相关论文
共 50 条
  • [1] MicroRNA-133b inhibits hepatocellular carcinoma cell progression by targeting Sirt1
    Tian, Zhijie
    Jiang, Hequn
    Liu, Ying
    Huang, Yong
    Xiong, Xin
    Wu, Hongwei
    Dai, Xiaozhen
    EXPERIMENTAL CELL RESEARCH, 2016, 343 (02) : 135 - 147
  • [2] miR-133b inhibits glioma cell proliferation and invasion by targeting Sirt1
    Li, Chuntao
    Liu, Zhixiong
    Yang, Kui
    Chen, Xin
    Zeng, Yu
    Liu, Jinfang
    Li, Zhenyan
    Liu, Yunsheng
    ONCOTARGET, 2016, 7 (24) : 36247 - 36254
  • [3] MicroRNA-133b Inhibits nTumor Cell Proliferation, Migration and Invasion by Targeting SUMO1 in Endometrial Carcinoma
    Liao, Lingyun
    Chen, Yun
    Zhou, Jieli
    Ye, Jing
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2021, 20
  • [4] MicroRNA-133b inhibits cell migration and invasion by targeting matrix metalloproteinase 14 in glioblastoma
    Chang, Liang
    Lei, Xuhui
    Qin, Yu
    Zhang, Xuexin
    Jin, Hua
    Wang, Chao
    Wang, Xin
    Li, Guofu
    Tan, Chunlei
    Su, Jun
    Oncology Letters, 2015, 10 (05) : 2781 - 2786
  • [5] MiR-217 Inhibits Proliferation, Migration, and Invasion by Targeting SIRT1 in Osteosarcoma
    He, Shaoxuan
    Wang, Zhihua
    Tang, Hao
    Dong, Junjie
    Qu, Yongzhou
    Lv, Jia
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2019, 34 (04) : 264 - 270
  • [6] MicroRNA-133b Inhibits Proliferation, Cellular Migration, and Invasion via Targeting LASP1 in Hepatocarcinoma Cells
    Li, Hui
    Xiang, Zhigang
    Liu, Yan
    Xu, Bin
    Tang, Jianzhou
    ONCOLOGY RESEARCH, 2017, 25 (08) : 1269 - 1282
  • [7] Procaine Inhibits Proliferation and Migration and Promotes Cell Apoptosis in Osteosarcoma Cells by Upregulation of MicroRNA-133b
    Ying, Boda
    Huang, Hong
    Li, Hongfei
    Song, Meng
    Wu, Sizhan
    Ying, Hongliang
    ONCOLOGY RESEARCH, 2017, 25 (09) : 1463 - 1470
  • [9] MicroRNA-138 inhibits cell proliferation in hepatocellular carcinoma by targeting Sirt1
    Luo, Jia
    Chen, Pan
    Xie, Wei
    Wu, Feiyue
    ONCOLOGY REPORTS, 2017, 38 (02) : 1067 - 1074
  • [10] microRNA-486 suppressed proliferation, migration and invasion of osteosarcoma cells via directly targeting SIRT1
    Shi, Yongxiang
    Liang, Chengzhen
    Li, Hao
    Shen, Weiliang
    Xiao, Yuxiang
    Chen, Qixin
    Chen, Weishan
    Ye, Zhaoming
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (09): : 9157 - 9165